Predicting relapse in Crohn's disease: a biopsychosocial model

Bitton, A.; Dobkin, P. L.; Edwardes, M. D.; Sewitch, M. J.; Meddings, J. B.; Rawal, S.; Cohen, A.; Vermeire, S.; Dufresne, L.; Franchimont, D.; Wild, G. E.
October 2008
Gut;Oct2008, Vol. 57 Issue 10, p1386
Academic Journal
Background: Crohn's disease (CD) is a chronic relapsing inflammatory bowel disorder. Both biological and psychosocial factors may modulate the illness experience. Aim: The aim of this study was to identify clinical, biological and psychosocial parameters as predictors of clinical relapse in quiescent CD. Methods: Patients in medically induced remission were followed prospectively for 1 year, or less if they relapsed. Disease characteristics were determined at baseline. Serum cytokines, anti-Saccharomyces cerevisiae antibodies, C-reactive protein (CAP), erythrocyte sedimentation rate and intestinal permeability were measured every 3 months. Psychological distress, perceived stress, minor life stressors and coping strategies were measured monthly. A time-dependent multivariate Cox regression model determined predictors of time to relapse. Results: 101 patients (60 females, 41 males) were recruited. Fourteen withdrew and 37 relapsed. CAP (HA = 1.5 per 10 mg/l, 95% Cl 1.1 to 1.9, p = 0.007), fistulising disease (HA = 3.2, 95% Cl, 1.1 to 9.4, p = 0.04), colitis (HA = 3.5 95% Cl 1.2 to 9.9, p = 0.02) and the interaction between perceived stress and avoidance coping (HA = 7.0 per 5 unit increase for both scales, 95% Cl 2.3 to 21.8, p = 0.003) were predictors of earlier relapse. Conclusions: In quiescent CD, a higher CAP, fistulising disease behaviour and disease confined to the colon were independent predictors of relapse. Moreover, patients under conditions of low stress and who scored low on avoidance coping )ie, did not engage in social diversion or distraction) were least likely to relapse. This study supports a biopsychosocial model of CD exacerbation.


Related Articles

  • Intestinal Permeability Test as a Predictor of Clinical Course in Crohn's Disease. D'Incà, Renata; Di Leo, Vincenza; Corrao, Giovanni; Martines, Diego; D'Odorico, Anna; Mestriner, Cinzia; Venturi, Carla; Longo, Giuseppe; Sturniolo, Giacomo Carlo // American Journal of Gastroenterology;Oct1999, Vol. 94 Issue 10, p2956 

    OBJECTIVE: The clinical course of Crohn's disease is often unpredictable. The aim of this study was to select the most useful parameters able to predict clinical relapses. METHODS: One hundred-thirty Crohn's disease patients in clinical remission were followed every 4 months for 2 yr or until...

  • Serum interleukin-8 levels may predict relapse in brucellosis. Demir, Nazlım Aktuğ; Ural, Onur // Turkish Journal of Medical Sciences;Oct2012, Vol. 42 Issue 5, p796 

    Aim: To investigate whether cytokines are effective in predicting relapses among patients with acute brucellosis. Materials and methods: This trial was conducted in 42 patients who were being followed-up with diagnosis of acute brucellosis. Serum samples were obtained on days 0 and 45. In...

  • Prognostic value of cytokines (TNF-α, IL-10, Leptin) and C-reactive protein serum levels in adult patients with nosocomial sepsis. Cesur, Salih; Şengül, Ali; Kurtoğlu, Yasemin; Kalpakçı, Yasin; Özel, Selcan Arslan; Bilgetürk, Aybars; Erdem, Hakan; Aslan, Turan; Kınıklı, Sami; Eyigün, Can Polat; Bıyıklı, Zeynep // Journal of Microbiology & Infectious Diseases;Jul2011, Vol. 1 Issue 3, p101 

    Objectives: The purpose of this trial was to investigate in patients with sepsis, the correlation between prognosis of disease and factors, which influence prognosis like gender, focus of infection, bacterial growth in blood culture, growing pathogens in addition to serum levels of cytokines...

  • Hypersensitivity vasculitis and cytokines. Nalbant, Selim; Koc, Bayram; Top, Cihan; Kucukardali, Yasar; Baykal, Yavuz; Danaci, Mehmet; Kocer, Ismail Hakki // Rheumatology International;Nov2002, Vol. 22 Issue 6, p244 

    Objective. Hypersensitivity vasculitis (HSV) is secondary vasculitis due to an immune response to exogenous substances. Because of the relative rarity of the vasculitides there are no reports on the role cytokines. This report evaluates some of cytokines which might be involved in...

  • The Relationship between Zinc Status and Inflammatory Marker Levels in Rural Korean Adults Aged 40 and Older. Jung, Sukyoung; Kim, Mi Kyung; Choi, Bo Youl // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Background: Serum cytokines and C-reactive protein (CRP) are known as one of the major risk factors in atherosclerosis. The antioxidant and anti-inflammatory properties of zinc have been suggested, but few data are available on the relationship between zinc status and inflammatory markers in...

  • What Should We Regard as an “Elevated” C-Reactive Protein Level? Kushner, Irving; Antonelli, Maria J. // Annals of Internal Medicine;8/18/2015, Vol. 163 Issue 4, p326 

    The article discusses a study proposing the adoption of a single standard to report C-reactive protein (CRP) levels. It analyzed the clinical findings of redness, swelling and pain as well as increased activation of inflammatory cytokines and transcription factors. It concludes that all serum...

  • Outcome Predictors for Thiopurine Maintenance Therapy in Patients with Crohn's Disease. Park, Jae; Cheon, Jae; Hong, Sung; Kim, Tae; Kim, Won // Digestive Diseases & Sciences;Jan2012, Vol. 57 Issue 1, p133 

    Background: Little is known about the factors that predict clinical relapse in Crohn's disease patients receiving thiopurine therapy to maintain remission. The objective of this study was, therefore, to investigate these factors. Methods: A total of 82 Crohn's disease patients who received their...

  • Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn's disease. Imaeda, Hirotsugu; Takahashi, Kenichiro; Fujimoto, Takehide; Bamba, Shigeki; Tsujikawa, Tomoyuki; Sasaki, Masaya; Fujiyama, Yoshihide; Andoh, Akira // Journal of Gastroenterology;Jan2014, Vol. 49 Issue 1, p100 

    Background/aim: The appearance of anti-adalimumab antibodies (AAAs) is associated with low serum adalimumab (ADA) trough levels and a decrease of clinical response. The goal of this study was to assess the accuracy and clinical utility of new immunoassays for serum ADA and AAA levels. Patients...

  • C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease. Hibi, Toshifumi; Sakuraba, Atsushi; Watanabe, Mamoru; Motoya, Satoshi; Ito, Hiroaki; Sato, Noriko; Yoshinari, Toru; Motegi, Kenta; Kinouchi, Yoshitaka; Takazoe, Masakazu; Suzuki, Yasuo; Matsumoto, Takayuki; Kawakami, Kazuhiko; Hirata, Ichiro; Tanaka, Shinji; Ashida, Toshifumi; Matsui, Toshiyuki // Journal of Gastroenterology;Feb2014, Vol. 49 Issue 2, p254 

    Background: The ability of serum infliximab level to predict clinical outcome in infliximab therapy in Crohn's disease is unclear. Here, we aimed to clarify the correlation between the timing of loss of response (LOR) to treatment and a decrease in serum infliximab level, and, in addition, to...


Read the Article


Sign out of this library

Other Topics